Dexlansoprazole (30 mg) Caps Capsule | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Dexlansoprazole (30 mg) Caps Capsule
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Capsule
Class: Proton Pump Inhibitor (Dual Release)
✓ Pan-India Monopoly PCD
✓ 2 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Dexlansoprazole (30 mg) Caps Capsule Brand Options (2 options)
Trumac Healthcare manufactures and supplies the following Dexlansoprazole (30 mg) Caps Capsule brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Dexlansoprazole (30 mg) Caps Capsule is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Dexlansoprazole (30 mg) Caps formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Symptomatic non-erosive GERD
- Maintenance of healed erosive oesophagitis
- Heartburn relief
- Acid-related dyspepsia
Mechanism of Action
Dexlansoprazole irreversibly binds gastric H+/K+-ATPase (proton pumps) in parietal cells, blocking final step of acid secretion. Dual delayed-release technology produces two release peaks for extended acid control.
Dosage & Administration
- Adults: 30 mg once daily for 4 weeks (symptomatic non-erosive GERD);
- maintenance of healed erosive oesophagitis: 30 mg daily for 6 months.
Side Effects
- Headache, diarrhoea, abdominal pain.
- Long-term: B12 deficiency, hypomagnesaemia, increased fracture risk, C.
- difficile infection.
Contraindications
- Hypersensitivity.
- Concurrent rilpivirine.
- Long-term use without indication.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Dexlansoprazole (30 mg) Caps Capsule
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 2 brand options for Dexlansoprazole (30 mg) Caps Capsule — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Dexlansoprazole (30 mg) Caps Capsule, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Dexlansoprazole (30 mg) Caps Capsule?
Trumac Healthcare is a WHO-GMP certified manufacturer of Dexlansoprazole (30 mg) Caps Capsule in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Dexlansoprazole (30 mg) Caps Capsule available for PCD pharma franchise on monopoly basis?
Yes. We offer Dexlansoprazole (30 mg) Caps Capsule for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Dexlansoprazole (30 mg) Caps Capsule?
Available pack sizes include: 10 x 10 (Alu Alu).
What is the MRP / trade price for Dexlansoprazole (30 mg) Caps Capsule?
MRPs range from ₹1190 to ₹1990 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Dexlansoprazole (30 mg) Caps Capsule?